| 22q11.2DS | 22q11.2 deletion syndrome |
| ASD | Autistic spectrum disorder |
| BDNF | Brain derived neurotropic factor |
| BBB | Blood–brain barrier |
| CCL2 | Chemokine ligand 2 |
| CCL5 | Chemokine ligand 5 |
| CXCL1 | Chemokine ligand 1 |
| CD3 | Cluster of differentiation 3 |
| CD4 | Cluster of differentiation 4 |
| COMT | catechol-O-methyltransferase |
| DGRC8 | DiGeorge syndrome critical region 8 |
| DGS | DiGeorge syndrome |
| GABA | Gamma-aminobutyric acid |
| IFNγ | Interferon gamma |
| IL-1 | Interleuchin-1 |
| IL-6 | Interleuchin-6 |
| IL-10 | Interleuchin-10 |
| IL-12 | Interleuchin-12 |
| miRNAs | microRNAs |
| NLR | Neutrophiles to leukocytes ratio |
| PGC-1α | PPARγ co-activator 1α |
| PRODH | Proline dehydrogenase |
| ROS | Reactive oxygen species |
| RNS | Reactive nitrogen species |
| SERCA2 | Sarcoendoplasmic reticulum calcium-ATPase type 2 |
| SNPs | Single nucleotide polymorphisms |
| SOD | Superoxide dismutase |
| SSD | Schizophrenia spectrum disorder |
| TBX1 | T-box transcription factor 1 |
| TCA | tricarboxylic acid |
| TH 1 | T-helper 1 cells |
| TH 2 | T-helper 2 cells |
| TH 17 | T-helper 17 cells |
| TNF-α | Tumor necrosis factor alpha |
| TXNRD2 | Thioredoxin reductase 2 |